Please Scroll Down to See Forums Below 
A new supplement to come to relieve joint pains
It conatins fatty acids
Before it is on the shelf, take your flax seed oil
02/08/02 - US nutraceutical company Imagenetix claims that results from a clinical trial on its product Celadrin, a natural nutritional supplement made of a combination of cetylated fatty acids, show that it promotes joint health.
The clinical trial is published in the current issue of the Journal of Rheumatology. In the double-blind, multi-centre, placebo-controlled trial, researchers examined the impact of a 68-day oral administration of Celadrin on 64 participants who were experiencing joint and mobility problems.
The company reports that after 68 days participants who consumed Celadrin showed healthy joint mobility, flexibility and function compared to those given the placebo.
Participants' responses to the Lequesne index indicated a significant shift towards functional improvement for the Celadrin group compared to the participants given the placebo.
Data from the study also indicated that Celadrin not only promoted joint flexibility, but also supported and promoted the ability to walk long distances. Imagenetix stressed that participants in the study exhibited no side effects.
"Celadrin is unique. It does not contain Glucosamine, Chondroitin, MSM or SAMe. Additionally, unlike many competitive products, with over 90,000,000 Celadrin pills distributed to date, we have no reported adverse side effects. Safe and effective products, available at a reasonable cost, and backed by solid scientific research continue to be a consumer priority.”
Reuters
It conatins fatty acids
Before it is on the shelf, take your flax seed oil
02/08/02 - US nutraceutical company Imagenetix claims that results from a clinical trial on its product Celadrin, a natural nutritional supplement made of a combination of cetylated fatty acids, show that it promotes joint health.
The clinical trial is published in the current issue of the Journal of Rheumatology. In the double-blind, multi-centre, placebo-controlled trial, researchers examined the impact of a 68-day oral administration of Celadrin on 64 participants who were experiencing joint and mobility problems.
The company reports that after 68 days participants who consumed Celadrin showed healthy joint mobility, flexibility and function compared to those given the placebo.
Participants' responses to the Lequesne index indicated a significant shift towards functional improvement for the Celadrin group compared to the participants given the placebo.
Data from the study also indicated that Celadrin not only promoted joint flexibility, but also supported and promoted the ability to walk long distances. Imagenetix stressed that participants in the study exhibited no side effects.
"Celadrin is unique. It does not contain Glucosamine, Chondroitin, MSM or SAMe. Additionally, unlike many competitive products, with over 90,000,000 Celadrin pills distributed to date, we have no reported adverse side effects. Safe and effective products, available at a reasonable cost, and backed by solid scientific research continue to be a consumer priority.”
Reuters
